Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiNardo

Showing results (841-850 of 1,482) with videos related to

Pageof 149
Sort By:
Cancer|January 23, 2019
Phase 1/2 study of DFP-10917 administered by continuous intravenous infusion in patients with recurrent or refractory acute myeloid leukemiaHagop M Kantarjian, Elias J Jabbour, Guillermo Garcia-Manero, et al.
The Lancet. Haematology|December 4, 2018
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 studyElias Jabbour, Nicholas J Short, Farhad Ravandi, et al.
Cancer|April 7, 2025
Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single-center, single-arm, phase 2 trialHannah Goulart, Hagop Kantarjian, Gautam Borthakur, et al.
Plos One|September 26, 2025
Clinical, laboratory and genetic factors associated with smoking in a Brazilian Sickle Cell Disease (SCD) cohortTheomario Cruz, Beatriz Araujo Oliveira, Mina Cintho Ozahata, et al.
Hemasphere|October 24, 2025
A Phase 2 study of CPX-351 in combination with venetoclax in patients with newly diagnosed high-risk acute myeloid leukemiaWei-Ying Jen, Jennifer Croden, Emmanuel Almanza-Huante, et al.
Transfusion|November 24, 2020
Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed ProgramCarla L Dinardo, Theo G M Oliveira, Shannon Kelly, et al.
Cancer|July 17, 2019
Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemiaKoji Sasaki, Hagop M Kantarjian, Tapan Kadia, et al.
Cancer|February 28, 2019
Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemiaChristopher B Benton, Prajwal C Boddu, Courtney D DiNardo, et al.
Cancers|January 11, 2022
Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaAmber Gibson, Adriana Trabal, David McCall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 13, 2022
Optimal Timing of Antiretroviral Therapy Initiation in Children and Adolescents With Human Immunodeficiency Virus-Associated Pulmonary TuberculosisAlexander Kay, Jose Mendez-Reyes, Tara Devezin, et al.
Pageof 149

Showing results (841-850 of 1,482) with videos related to

Sort By:
Pageof 149
Cancer|January 23, 2019
Phase 1/2 study of DFP-10917 administered by continuous intravenous infusion in patients with recurrent or refractory acute myeloid leukemiaHagop M Kantarjian, Elias J Jabbour, Guillermo Garcia-Manero, et al.
The Lancet. Haematology|December 4, 2018
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 studyElias Jabbour, Nicholas J Short, Farhad Ravandi, et al.
Cancer|April 7, 2025
Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single-center, single-arm, phase 2 trialHannah Goulart, Hagop Kantarjian, Gautam Borthakur, et al.
Plos One|September 26, 2025
Clinical, laboratory and genetic factors associated with smoking in a Brazilian Sickle Cell Disease (SCD) cohortTheomario Cruz, Beatriz Araujo Oliveira, Mina Cintho Ozahata, et al.
Hemasphere|October 24, 2025
A Phase 2 study of CPX-351 in combination with venetoclax in patients with newly diagnosed high-risk acute myeloid leukemiaWei-Ying Jen, Jennifer Croden, Emmanuel Almanza-Huante, et al.
Transfusion|November 24, 2020
Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed ProgramCarla L Dinardo, Theo G M Oliveira, Shannon Kelly, et al.
Cancer|July 17, 2019
Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemiaKoji Sasaki, Hagop M Kantarjian, Tapan Kadia, et al.
Cancer|February 28, 2019
Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemiaChristopher B Benton, Prajwal C Boddu, Courtney D DiNardo, et al.
Cancers|January 11, 2022
Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaAmber Gibson, Adriana Trabal, David McCall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 13, 2022
Optimal Timing of Antiretroviral Therapy Initiation in Children and Adolescents With Human Immunodeficiency Virus-Associated Pulmonary TuberculosisAlexander Kay, Jose Mendez-Reyes, Tara Devezin, et al.
Pageof 149